United Therapeutics Trading Volume Drops 33.16% to 499th Position Despite 2.08% Stock Price Increase
On June 2, 2025, United Therapeutics (UTHR) saw a trading volume of $189 million, marking a 33.16% decrease from the previous day. This placed the company at the 499th position in terms of trading volume for the day. The stock price of United Therapeutics rose by 2.08%.
United Therapeutics has been assigned an "Overweight" rating by Cantor Fitzgerald, a leading financial services firm. This rating reflects a positive outlook on the company's future performance and potential for growth. The average rating for United Therapeutics is overweight, with a mean price target of $401.80, according to analysts polled by FactSet. This indicates a strong consensus among analysts regarding the company's prospects.
Cantor Fitzgerald analyst Olivia Brayer initiated coverage on United Therapeutics, further supporting the positive sentiment surrounding the company. The initiation of coverage by a reputable firm like Cantor Fitzgerald is often seen as a vote of confidence in the company's future performance. This move is likely to attract more investor attention and potentially drive further stock price appreciation.